Challenges faced by the biotech company:
- Difficulty storing and managing large-volume (1000L) pharmaceutical drug substances.
- Need to maintain strict temperature traceability during storage and transport.
- Lack of adequate, flexible storage capacity at both the U.S. site and European CDMO partners.
- Risk of supply chain disruption due to lack of centralized and secure storage.
- Requirement to remain GMP-compliant across international supply chain nodes.